12/08/2017 | Alex Huang
Aqueous angiography in living patients…
12/08/2017 | Michael O’Rourke
Sustained-release drug delivery technologies over time, and how future innovators should proceed…
12/07/2017 | Elizabeth Yeu
Combating the modern dry eye epidemic.
12/07/2017 | Pablo Artal
It’s difficult to remember all aspects of your training – especially optics principles…
12/07/2017 | Chelvin Sng
Chelvin Sng, Consultant Ophthalmologist, National University Hospital, Singapore
12/07/2017 | David A. Eichenbaum
Placing the HAWK/HARRIER data in the wider context of nAMD anti-VEGF trial data.
12/07/2017 | Jesse Berry
It shouldn't be about epi-on or epi-off CXL… The focus should be on what's best for patients.
12/07/2017 | Richard L. Lindstrom
My words of wisdom on working with industry to drive ophthalmic innovation.
12/07/2017 | Ruth Steer
A beautiful image of an embryonic eye.
12/07/2017 | Mark Hillen
Can brolucizumab extend the AMD anti-VEGF treatment interval?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: